[IHH] YoY Annual (Unaudited) Result on 31-Dec-2016 [#4]

Stock
[IHH] IHH HEALTHCARE BERHAD
Announcement Date
23-Feb-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Dec-2016 [#4]
Profit Trend
YoY- -34.43%
Quarter Report
Latest QR
Upcoming QR
IHH's Result
IHH's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 14,912,485 11,520,932 11,142,639 10,021,885 8,455,468 7,344,019 6,756,451 14.09%
PBT 1,042,724 752,470 1,164,453 877,617 1,217,539 1,221,176 881,562 2.83%
Tax -527,882 -262,610 -334,625 -269,625 -165,444 -277,892 -147,703 23.63%
NP 514,842 489,860 829,828 607,992 1,052,095 943,284 733,859 -5.73%
-
NP to SH 551,476 627,687 969,953 612,353 933,903 754,291 631,159 -2.22%
-
Tax Rate 50.63% 34.90% 28.74% 30.72% 13.59% 22.76% 16.75% -
Total Cost 14,397,643 11,031,072 10,312,811 9,413,893 7,403,373 6,400,735 6,022,592 15.62%
-
Net Worth 22,373,675 21,152,362 21,916,086 21,975,571 22,321,758 19,428,708 18,009,935 3.68%
Dividend
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Div 350,959 252,817 247,173 246,916 246,195 244,899 1,622 144.91%
Div Payout % 63.64% 40.28% 25.48% 40.32% 26.36% 32.47% 0.26% -
Equity
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Net Worth 22,373,675 21,152,362 21,916,086 21,975,571 22,321,758 19,428,708 18,009,935 3.68%
NOSH 8,773,990 8,769,296 8,239,109 8,230,551 8,206,528 8,163,322 8,112,583 1.31%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 3.45% 4.25% 7.45% 6.07% 12.44% 12.84% 10.86% -
ROE 2.46% 2.97% 4.43% 2.79% 4.18% 3.88% 3.50% -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
RPS 169.96 136.71 135.24 121.76 103.03 89.96 83.28 12.61%
EPS 5.28 6.54 11.31 7.44 11.38 9.24 7.78 -6.25%
DPS 4.00 3.00 3.00 3.00 3.00 3.00 0.02 141.72%
NAPS 2.55 2.51 2.66 2.67 2.72 2.38 2.22 2.33%
Adjusted Per Share Value based on latest NOSH - 8,175,192
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
RPS 169.21 130.73 126.43 113.72 95.94 83.33 76.67 14.09%
EPS 6.26 7.12 11.01 6.95 10.60 8.56 7.16 -2.21%
DPS 3.98 2.87 2.80 2.80 2.79 2.78 0.02 141.52%
NAPS 2.5387 2.4001 2.4868 2.4936 2.5328 2.2046 2.0436 3.68%
Price Multiplier on Financial Quarter End Date
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Date 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 -
Price 5.47 5.39 5.86 6.35 6.58 4.82 3.86 -
P/RPS 3.22 3.94 4.33 5.21 6.39 5.36 4.63 -5.87%
P/EPS 87.03 72.37 49.78 85.35 57.82 52.16 49.61 9.81%
EY 1.15 1.38 2.01 1.17 1.73 1.92 2.02 -8.95%
DY 0.73 0.56 0.51 0.47 0.46 0.62 0.01 104.36%
P/NAPS 2.15 2.15 2.20 2.38 2.42 2.03 1.74 3.58%
Price Multiplier on Announcement Date
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Date 28/02/20 27/02/19 27/02/18 23/02/17 25/02/16 26/02/15 27/02/14 -
Price 5.70 5.66 6.11 6.15 6.53 5.48 3.81 -
P/RPS 3.35 4.14 4.52 5.05 6.34 6.09 4.57 -5.04%
P/EPS 90.69 75.99 51.90 82.66 57.38 59.31 48.97 10.81%
EY 1.10 1.32 1.93 1.21 1.74 1.69 2.04 -9.77%
DY 0.70 0.53 0.49 0.49 0.46 0.55 0.01 102.94%
P/NAPS 2.24 2.25 2.30 2.30 2.40 2.30 1.72 4.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment